Vera Therapeutics (NASDAQ:VERA) PT Raised to $64.00 at Guggenheim
MarketBeatGuggenheim raised their target price on Vera Therapeutics from $56.00 to $64.00 and gave the stock a “buy” rating in a research report on Monday.
Guggenheim raised their target price on Vera Therapeutics from $56.00 to $64.00 and gave the stock a “buy” rating in a research report on Monday.